Phase 1 Study of Multikine in the Treatment of Perianal Warts

Trial Profile

Phase 1 Study of Multikine in the Treatment of Perianal Warts

Discontinued
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Buffy coat interleukins (Primary)
  • Indications Anal cancer; Anal dysplasia; Anal intraepithelial neoplasia; Genital warts
  • Focus Therapeutic Use
  • Sponsors CEL-SCI Corporation
  • Most Recent Events

    • 24 Aug 2016 Last checked against ClinicalTrials.gov record.
    • 17 Aug 2016 Status changed from recruiting to discontinued.
    • 09 Feb 2016 According to CEL-SCI media release, this study in expected to complete in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top